SCHEMBL79028

SCHEMBL79028

[O]CCCC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL294198 0.90
SCHEMBL1678731 0.87 ALOX15 (0.32)
SCHEMBL2540702 0.87 ALOX15 (0.32)
SCHEMBL1862141 0.87 ALOX15 (0.32)
SCHEMBL7274009 0.87 ALOX15 (0.32)
SCHEMBL7850745 0.87 ALOX15 (0.32)
SCHEMBL292474 0.87 ALOX15 (0.32)
SCHEMBL7691930 0.87 ALOX15 (0.32)
SCHEMBL10126 0.77
SCHEMBL8984071 0.76 ALOX15 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2127 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118005608-A Triazole small molecular organic compound for inhibiting mitochondrial oxidative phosphorylation by specific targeting complex I and application thereof 华东师范大学 2024-05-10 CN claimed
US-20230348421-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) 2023-11-02 US claimed
WO-2023147513-A2 COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF WASHINGTON UNIVERSITY (US) 2023-08-03 WO claimed
EP-4186893-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Geneora Pharma (Shijiazhuang) Co., Ltd. (CN) 2023-05-31 EP claimed
US-11528907-B2 Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides BAYER AKTIENGESELLSCHAFT (DE) 2022-12-20 US claimed
CN-114728933-A 5-HT2AReceptor inhibitor or inverse agonist, preparation method and application thereof 山东绿叶制药有限公司 2022-07-08 CN claimed
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-06-16 US claimed
EP-3936192-A1 PYRROLOPYRAZOLE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2022-01-12 EP claimed
US-20210386070-A1 NOVEL HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2021-12-16 US claimed
CN-113543852-A Pyrrolopyrazole derivatives 第一三共株式会社 2021-10-22 CN claimed
US-5843975-A Oxazolidinone derivatives, their preparation and therapeutical use SYNTHELABO (FR) 1998-12-01 US claimed
EP-0808304-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE &amp; CO. (US) 1997-11-26 EP claimed
US-5686470-A 2, 3-substituted pyridines for the treatment of inflammation WEIER RICHARD M (US) 1997-11-11 US claimed
WO-1996024584-A1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-15 WO claimed
EP-0296749-B1 (Substituted aralkyl) heterocyclic compounds ZENECA LTD (GB) 1994-10-26 EP claimed
US-4999364-A Azole derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-03-12 US claimed
US-4935437-A (Substituted aralkyl) heterocyclic compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-19 US claimed
EP-0354683-A1 Azole derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-02-14 EP claimed
EP-0354689-A1 Diphenylethane derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-02-14 EP claimed
EP-0296749-A1 (Substituted aralkyl) heterocyclic compounds ZENECA LIMITED (GB) 1988-12-28 EP claimed